軟件股繼續走強 誠邁科技漲停
格隆匯1月16日丨軟件股繼續走強,誠邁科技漲停,科創板虹軟科技漲超13%,寶信軟件、卓易信息漲超7%,東方國信、海聯訊、龍軟科技、中國軟件等紛紛上漲。Gartner的最新預測顯示,2020年全球IT支出將達到3.9萬億美元,比2019年增長3.4%。預計2021年全球IT支出將突破4萬億美元大關。Gartner認為,今年增長最快的主要市場將是軟件,該市場將實現10.5%的兩位數增長。此外,工信部近日宣佈,將建設中國軟件名城和軟件名園,加快培育軟件名企,根據巨豐投 顧,符合國產化的產品和系統級服務有望得到快速發展,從信息技術體系的分類來看,主要包括IT硬件設施、基礎軟件、應用軟件、安全軟件,利好國產軟件廠商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.